Nayereh G. Pezeshkian

Nayereh Pezeshkian practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Nayereh Pezeshkian's NPI, 1538362017, was assigned on June 11, 2007. Nayereh Pezeshkian holds California license A77356.

Nayereh Pezeshkian's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Nayereh Pezeshkian's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. Nayereh Pezeshkian is also affiliated with Sutter Roseville Medical Center. The medical group on file is UC Davis Medical Group. Dmand AI also links Nayereh Pezeshkian to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nayereh Pezeshkian practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Nayereh Pezeshkian's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Nayereh Pezeshkian is licensed in California.

CMS data shows 2,021 Medicare services from Nayereh Pezeshkian across 22 procedure codes in 2024, for 570 Medicare patients. Medicare paid $94,360 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 570 Medicare patients who saw Nayereh Pezeshkian in 2024. The largest group is 75 to 84, with 234 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nayereh Pezeshkian's median patient age at 71, with 46% women.

In 2024, Nayereh Pezeshkian wrote 874 Medicare Part D claims for 180 patients. 82% of them were for generic drugs. CMS names the drug for 748 of them, across 16 drugs with 11 or more claims each, at $208,892 in total drug cost. In 2023, CMS named 709 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Nayereh Pezeshkian for performance year 2024, reported as part of a group. Nayereh Pezeshkian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Nayereh Pezeshkian as offering telehealth. CMS counts 32 procedures of pacemaker insertion or repair by Nayereh Pezeshkian, more than 80% of the clinicians it reports for that procedure.

CMS Open Payments shows 105 general payments to Nayereh Pezeshkian from 12 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 62% of the total. Medtronic Vascular, Inc. paid the most, $2,667.